Quick Answer
ESCALON MEDICAL CORP reported Diluted EPS of $0.00 per share for fiscal year 2025.
ESCALON MEDICAL CORP Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.00 | +100.0% |
| 2024 | -$0.02 | -166.7% |
| 2023 | $0.03 | — |
| 2022 | $0.00 | +100.0% |
| 2021 | -$0.01 | +88.9% |
| 2020 | -$0.09 | -125.0% |
| 2019 | -$0.04 | -166.7% |
| 2018 | $0.06 | +140.0% |
| 2016 | -$0.15 | -114.3% |
| 2015 | -$0.07 | -40.0% |
| 2014 | -$0.05 | -114.3% |
| 2013 | $0.35 | +144.3% |
| 2012 | -$0.79 | -2.6% |
| 2011 | -$0.77 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $0.01 | -50.0% | +133.3% |
| September 30, 2025 | -$0.03 | -200.0% | -250.0% |
| March 31, 2025 | $0.02 | +200.0% | +0.0% |
| December 31, 2024 | $0.02 | +300.0% | +300.0% |
| September 30, 2024 | -$0.01 | — | +50.0% |
| March 31, 2024 | -$0.02 | -150.0% | -100.0% |
| December 31, 2023 | -$0.01 | — | — |
| September 30, 2023 | $0.00 | +100.0% | -100.0% |
- ESCALON MEDICAL CORP showed an increase of +100.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2011–2025 period, ESCALON MEDICAL CORP’s diluted eps has grown by 100.0% (from $0.77 per share (loss) to $0.00 per share).
- The most recent figure is from ESCALON MEDICAL CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: